Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana

Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana

PURPOSEBreast cancer (BC) is the most common female cancer worldwide, and the burden is increasing across sub-Saharan Africa. For women with hormone receptor–positive (HR+) cancers, endocrine therapy (ET) taken for 5-10 years can reduce the risk of recurrence by half. We explored experiences with ET...

Full description

Saved in:
Bibliographic Details
Main Authors: James R. Wester, Rachel B. Wagner, Bosa Motladiile, Isaac Nkele, Nkhabe Chinyepi, Moeketsi J. Makhema, Tara M. Friebel-Klingner, Peter Vuylsteke, Shahin Lockman, Scott Dryden-Peterson, Racquel E. Kohler
Format: Article
Language:English
Published: American Society of Clinical Oncology 2024-12-01
Series:JCO Global Oncology
Online Access:https://ascopubs.org/doi/10.1200/GO.24.00180
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ascopubs.org/doi/10.1200/GO.24.00180

Similar Items